The Andersons (ANDE)
(Delayed Data from NSDQ)
$48.98 USD
+0.29 (0.60%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $48.96 -0.02 (-0.04%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$48.98 USD
+0.29 (0.60%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $48.96 -0.02 (-0.04%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Earnings Preview: The Andersons (ANDE) Q4 Earnings Expected to Decline
by Zacks Equity Research
Andersons (ANDE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Andersons (ANDE) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, The Andersons (ANDE) closed at $37.90, marking a -0.37% move from the previous day.
The Andersons (ANDE) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, The Andersons (ANDE) closed at $37.90, marking a +0.21% move from the previous day.
The Andersons (ANDE) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, The Andersons (ANDE) closed at $37.40, marking a +1.16% move from the previous day.
Zacks Value Trader Highlights: AbbVie, The Andersons and Ingredion
by Zacks Equity Research
AbbVie, The Andersons and Ingredion are highlighted in this Zacks Value Traders article.
3 Value Stocks Breaking out in 2022
by Tracey Ryniec
Not all stocks are selling off to start 2022. These cheap, top Zacks Ranked stocks are doing the opposite.
What Makes Andersons (ANDE) a Good Fit for "Trend Investing"
by Zacks Equity Research
Andersons (ANDE) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
The Andersons (ANDE) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
The Andersons (ANDE) closed the most recent trading day at $39.28, moving -0.51% from the previous trading session.
The Andersons (ANDE) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, The Andersons (ANDE) closed at $39.18, marking a +0.51% move from the previous day.
The Andersons (ANDE) Stock Moves -0.94%: What You Should Know
by Zacks Equity Research
The Andersons (ANDE) closed the most recent trading day at $39.06, moving -0.94% from the previous trading session.
Is Alpha Metallurgical (AMR) Stock Outpacing Its Basic Materials Peers This Year?
by Zacks Equity Research
Here is how Alpha Metallurgical (AMR) and The Andersons (ANDE) have performed compared to their sector so far this year.
The Andersons (ANDE) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
The Andersons (ANDE) closed at $39.24 in the latest trading session, marking a +1.37% move from the prior day.
The Andersons (ANDE) Is Up 1.82% in One Week: What You Should Know
by Zacks Equity Research
Does The Andersons (ANDE) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zacks Investment Ideas feature highlights: The Andersons, West Fraser Timber and Bunge
by Zacks Equity Research
Zacks Investment Ideas feature highlights: The Andersons, West Fraser Timber and Bunge.
S&P 500 Set To Notch New All-Time Closing High: 3 Prosperous Strong Buys
by Bryan Hayes
S&P 500 Set To Notch New All-Time Closing High: 3 Prosperous Strong Buys
3 Agriculture Stocks Poised to Continue Winning Streaks in 2022
by Namrata Chatterjee
The agriculture sector continues to gain from upbeat commodity prices. Nutrien (NTR), The Andersons, Inc. (ANDE) and CF Industries Holdings, Inc. (CF) are poised to benefit from this trend.
How The Andersons (ANDE) Stock Stands Out in a Strong Industry
by Zacks Equity Research
The Andersons (ANDE) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Zacks Value Trader Highlights: CF Industries, Mosaic Company, Intrepid Potash, Nutrien and The Andersons
by Zacks Equity Research
Zacks Value Trader Highlights: CF Industries, Mosaic Company, Intrepid Potash, Nutrien and The Andersons
5 Stocks for the 2022 Agriculture Bull Market
by Tracey Ryniec
It's the hottest agriculture market in a decade but the fertilizers and agribusiness companies are still cheap.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
New Strong Sell Stocks for November 4th
by Zacks Equity Research
ALX, RDY, HSC, LAWS, and ANDE have been added to the Zacks Rank #5 (Strong Sell) List on November 4, 2021.
The Andersons (ANDE) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Andersons (ANDE) delivered earnings and revenue surprises of 225.00% and 26.52%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate The Andersons (ANDE) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Andersons (ANDE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why The Andersons (ANDE) is a Strong Momentum Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Should Value Investors Consider Andersons (ANDE) Stock?
by Zacks Equity Research
Let's see if Andersons (ANDE) stock is a good choice for value-oriented investors right now from multiple angles.